polymyalgia rheumatica and methotrexate (MTX) Archives

Abstract Number: 742 • ACR/ARP Annual Meeting 2019
Polymyalgia Rheumatica: New Therapeutic Strategy Based on Low Dose Metrotexate Plus Local Infiltration with Corticosteroids
Miriam Retuerto¹, Pilar Fernández-Dapica ², Patricia Lavilla ³, Fernando Lozano ³, M. Eva Vallejo ⁴ and José Luis Pablos ⁵, ¹Rheumatology Department. Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, ²Hospital universitario 12 de octubre, Instituto de investigacion hospital 12 de octubre (i+12), Madrid, Spain, ³Rheumatology Department. Hospital universitario 12 de octubre, Instituto de investigacion hospital 12 de octubre (i+12), Madrid, Spain, ⁴Facultad de CC. EE y Empresariales, Universidad de Leon, Leon, Spain, ⁵Rheumatology Department. Hospital universitario 12 de octubre, Instituto de investigacion hospital 12 de octubre (i+12), Universidad Complutense de Madrid, Madrid, Spain
Background/Purpose: Polymyalgia rheumatic (PMR) is a common rheumatic inflammatory disease in the elderly. Glucocorticoids (GC) are the therapeutic mainstay in PMR but induce significant toxicity…
Abstract Number: 760 • ACR/ARP Annual Meeting 2019
Prescribing Methotrexate in Polymyalgia Rheumatica: A Missed Opportunity?
Diane Marsman¹, Aatke van der Maas ¹, Nathan den Broeder ¹, Thomas Bolhuis ¹, Nadine Boers ², Alfons den Broeder ¹ and Frank van den Hoogen ¹, ¹Sint Maartenskliniek, Nijmegen, Netherlands, ²Sint Maartenskliniek, Nijmegen
Background/Purpose: Patients with polymyalgia rheumatica (PMR) and giant cell arthritis (GCA) constitute approximately 20% of diseases chronically treated with glucocorticoids (GC) with a daily dose…

Abstracts tagged "polymyalgia rheumatica and methotrexate (MTX)"

Polymyalgia Rheumatica: New Therapeutic Strategy Based on Low Dose Metrotexate Plus Local Infiltration with Corticosteroids

Prescribing Methotrexate in Polymyalgia Rheumatica: A Missed Opportunity?